Riskpilot← Back to searchSign inGet full accessAffycon ApS
APSActiveCVR 37049794Espedalen 89Research and experimental development on natural sciences and engineering · NACE 7210Est. 2015— employeeswww.affycon.com
Revenue 2024
DKK 10K
+186% vs 2023
EBITDA margin
100.0%
+186% vs 2023
Equity ratio
-1396.2%
Financial strength
Net profit 2024
DKK 1K
+119% vs 2023
| Revenue | DKK 10K | +186% |
| EBITDA | DKK 10K | +186% |
| Net profit | DKK 1K | +119% |
| Total assets | DKK 14K | -64% |
| Equity | DKK -199K | +1% |
| Employees | — | — |
Legal name
Affycon ApS
CVR number
37049794
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. september 2015
Share capital
DKK 72.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem, eller af den samlede
bestyrelse.
Company purpose
Virksomhedens formål er udvikle og producere kemikalier, metoder, know how og patentrettigheder til at konjugere molekyler og biomolekyler til proteiner ved affinitets konjugering og at kommercialisere disse rettigheder ved egne aktiviteter eller ved at lave licensaftaler med samarbejdspartnere, samt enhver aktivitet der står i forbindelse hermed.
Address
Espedalen 89
Phone
+4560202725
Website
www.affycon.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -79 | -104 | -0 | -71 | -39 | 11 | -3 | 3 | 10 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -79 | -104 | -0 | -71 | -39 | 11 | -3 | 3 | 10 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -79 | -104 | -0 | -71 | -39 | 11 | -3 | 3 | 10 |
| Net financials | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | -9 |
| Profit before tax | -79 | -104 | -0 | -71 | -39 | 11 | -3 | -5 | 1 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -79 | -104 | -0 | -71 | -39 | 11 | -3 | -5 | 1 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 65 | 1 | 4 | 1 | 2 | 83 | 69 | 40 | 14 |
| Equity | -7 | -39 | 72 | 1 | 33 | 83 | 69 | -200 | -199 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 223 | 209 |
| Short-term debt | 72 | 40 | -67 | 0 | -31 | 0 | 0 | 17 | 5 |
| Total debt | 72 | 40 | -67 | 0 | -31 | 0 | 0 | 240 | 214 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20162024
Equity ratio
-1396.2%
This company
38.2%
Market median
-3755% vs market
20162024
Return on equity
103000.0%
This company
18.4%
Market median
+559683% vs market
20162024
Net profit margin
10.3%
This company
8.1%
Market median
+27% vs market
20162024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20162024
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2015-09-01 – 2016-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gothelf ApS | Company | 50.0% | 50.0% | 2019 |
| Individual | 15.0% | 15.0% | 2016 | |
MSci Invest Aps | Company | 15.0% | 15.0% | 2019 |
| Individual | 10.0% | 10.0% | 2016 | |
| Individual | 10.0% | 10.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MSci Invest Aps
Affycon ApS Board members of Affycon ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Vesterager Gothelf | Chairman | 0 companies |
| Michael Rosholm Mortensen | Board of Directors | 0 companies |